Stay updated on Biomarker-Directed Therapy in mCRC Clinical Trial
Sign up to get notified when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.

Latest updates to the Biomarker-Directed Therapy in mCRC Clinical Trial page
- Check2 days agoChange DetectedAdded new Locations across multiple regions and countries (e.g., Rio Grande do Sul, São Paulo, Apulia, Campania, Emilia-Romagna, Lazio, Lombardy, Tuscany, Veneto, Guanajuato, Oaxaca, Querétaro, Bashkortostan Republic, Moscow Oblast, Alicante, Balearic Islands, Barcelona, Cantabria, Cordoba, Guipuzcoa, LA Coruña, Madrid, Navarre, Principality of Asturias, Tenerife) and updated the Locations section; removed several previously listed locations as part of a revision from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page. This is a minor update to revision metadata and does not affect study details.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded a PubMed publication note indicating automatic PubMed-based publications and a revision banner for v3.3.1. Removed the previous PubMed publication note and the v3.2.0 revision.SummaryDifference0.0%

- Check38 days agoChange DetectedThe funding/operating-status notice was removed from the page; the study details and other content remain unchanged.SummaryDifference0.1%

- Check52 days agoChange DetectedNo substantive differences detected between the two screenshots; the page content and layout appear unchanged. The study details, eligibility criteria, and outcomes sections remain the same as before.SummaryDifference0.1%

- Check81 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference1%

Stay in the know with updates to Biomarker-Directed Therapy in mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Biomarker-Directed Therapy in mCRC Clinical Trial page.